Allergy Injection Medication: Four Categories, One Disease-Modifier
Allergy injection medication encompasses four distinct categories: SCIT (allergen extract — the only disease-modifying option per Cox 2011); biologic injections (Xolair, Dupixent, Tezspire — FDA-approved drugs treating disease without inducing tolerance); depot corticosteroids (Kenalog/Depo-Medrol — AAAAI-discouraged for routine use); and epinephrine auto-injectors (emergency rescue only). SCIT is allergen extract regulated by FDA CBER, not a pharmaceutical drug from FDA CDER.
6 peer-reviewed sources
Allergy injection medications include SCIT (allergen extract — disease-modifying), Xolair/Dupixent/Tezspire (biologic drugs — disease-treating not tolerance-inducing), Kenalog/Depo-Medrol (depot steroids — discouraged for routine use), and epinephrine (emergency rescue only).
The essentials
Allergy injection medication is an umbrella search query that leads to multiple distinct injectable interventions, only one of which modifies the underlying allergic disease long-term. Understanding the four categories prevents costly mismatches between patient needs and treatment choice.
Category 1 — SCIT (subcutaneous immunotherapy): Allergen extract custom-mixed in the allergist's office from FDA-licensed raw materials (Greer/Stallergenes, ALK-Abelló, HollisterStier). Regulated by FDA's Center for Biologics Evaluation and Research (CBER), not the Center for Drug Evaluation and Research (CDER). Billed under CPT 95115/95117 (injection) and 95165 (extract preparation). The 3-to-5-year course per Cox 2011 PP3 (JACI 2011;127[1 Suppl]:S1-S55) induces allergen-specific regulatory T-cell tolerance and blocking IgG4 antibodies, producing durable post-treatment remission per Durham 1999 NEJM. This is the only injection-based allergy intervention classified as disease-modifying.
Category 2 — Biologic injections: (a) Xolair (omalizumab, Genentech/Novartis) — anti-IgE monoclonal antibody, FDA-approved 2003 for moderate-to-severe persistent allergic asthma; expanded February 16, 2024 for IgE-mediated food allergy age ≥1 year per OUtMATCH NEJM 2024 trial; subcutaneous q2-4 weeks. (b) Dupixent (dupilumab, Regeneron/Sanofi) — anti-IL-4 receptor alpha, FDA-approved March 2017 for atopic dermatitis, October 2018 for asthma; subcutaneous q2 weeks. (c) Tezspire (tezepelumab-ekko, Amgen/AstraZeneca) — anti-TSLP, FDA-approved December 17, 2021 for severe asthma age ≥12; subcutaneous 210 mg q4 weeks. These are pharmaceutical drug products regulated by FDA CDER. They treat IgE-mediated or Th2-mediated disease without inducing allergen-specific tolerance — symptoms return on discontinuation.
Category 3 — Depot corticosteroids: Kenalog-40 (triamcinolone acetonide, first FDA-approved February 1, 1965) and Depo-Medrol (methylprednisolone acetate). Single intramuscular injections providing days-to-3-weeks of symptom suppression by broadly dampening the immune response. The AAAAI/ACAAI Joint Task Force Rhinitis Practice Parameter explicitly discourages single parenteral corticosteroid administration for routine allergic rhinitis and states that recurrent administration is contraindicated due to HPA-axis suppression and systemic glucocorticoid risks.
Category 4 — Epinephrine (emergency rescue only): EpiPen (FDA-approved 1987), Auvi-Q (2012), and the needle-free neffy nasal spray (epinephrine 2 mg, FDA-approved August 9, 2024; pediatric 1 mg approved March 5, 2025). These reverse acute anaphylaxis; they are not chronic allergy treatments.
Curex's at-home IgE testing with allergist review identifies the specific allergen sensitization pattern that determines whether immunotherapy is a candidate — the same workup that precedes any decision about injection-based allergy treatment.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
The four categories of injectable allergy medication serve entirely different clinical purposes. The choice depends on whether the goal is disease modification (SCIT), disease control (biologics), short-term symptom suppression (depot steroids, discouraged), or emergency reversal (epinephrine).
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergen extract — not a drug) | |||||
Xolair (omalizumab) — anti-IgE biologic | |||||
Dupixent (dupilumab) — anti-IL-4Rα | |||||
Kenalog / Depo-Medrol (depot corticosteroids) | |||||
SLIT drops |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex delivers the disease-modifying allergy injection itself at home: a personalized SCIT serum sterile-compounded to USP <797> standards, prescribed by a board-certified allergist and self-administered as one weekly shot for $129/month. The first dose and every dose change are supervised live over Zoom and a prescribed epinephrine auto-injector is confirmed on hand — the only injection-based disease-modifying option, now without weekly clinic visits (FDA-approved SLIT tablets remain a needle-free alternative).
See if at-home shots are right for youFrequently asked questions
What injection medications are used for allergies?
Four categories of injection medications are used for allergies: (1) SCIT — allergen extract (not a conventional drug), the 3-5 year immunotherapy course; (2) Biologic injections — Xolair (omalizumab, anti-IgE), Dupixent (dupilumab, anti-IL-4Rα), Tezspire (tezepelumab, anti-TSLP) — FDA-approved pharmaceutical drugs treating specific conditions; (3) Depot corticosteroids — Kenalog-40 and Depo-Medrol — IM injections providing short-term symptom suppression, discouraged for routine use by the AAAAI/ACAAI rhinitis practice parameter; (4) Epinephrine auto-injectors (EpiPen, Auvi-Q, neffy) — emergency rescue only, not chronic treatment.
What is the difference between SCIT and biologic allergy injections?
SCIT (subcutaneous immunotherapy) uses allergen extract — the same proteins you are allergic to — to train your immune system over 3-5 years to tolerate those allergens through regulatory T-cell induction and blocking IgG4 antibodies. After completing the course, benefits persist for years without further injections; for eligible maintenance patients Curex delivers that SCIT as one weekly self-administered shot at home for $129/month, with the first dose and dose changes supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand. Biologic injections like Xolair (anti-IgE), Dupixent (anti-IL-4Rα), and Tezspire (anti-TSLP) are pharmaceutical monoclonal antibodies that block upstream inflammatory pathways. They are highly effective for their indicated conditions, but they treat disease without inducing allergen-specific tolerance — symptoms return when the biologic is discontinued.
What is Xolair used for in allergy treatment?
Xolair (omalizumab) is an anti-IgE monoclonal antibody indicated for: moderate-to-severe persistent allergic asthma in patients aged 6 years and older with confirmed IgE sensitization to a year-round allergen not controlled by inhaled corticosteroids; chronic spontaneous urticaria (CSU) in patients aged 12 years and older uncontrolled by antihistamines; chronic rhinosinusitis with nasal polyps (CRSwNP) as an add-on to intranasal steroids; and IgE-mediated food allergy in patients aged 1 year and older (FDA-approved February 16, 2024 based on the OUtMATCH trial). Xolair is a subcutaneous injection, not an IV infusion, given every 2-4 weeks in a supervised clinical setting.
Are depot corticosteroid allergy shots safe?
Depot corticosteroid injections (Kenalog-40/triamcinolone acetonide and Depo-Medrol/methylprednisolone acetate) are FDA-approved medications but carry significant systemic risks with regular use. A single 80-120 mg methylprednisolone acetate injection suppresses the hypothalamic-pituitary-adrenal axis for weeks. Recurrent administration risks adrenal insufficiency, osteoporosis, weight gain, hyperglycemia, and other glucocorticoid side effects. The AAAAI/ACAAI Joint Task Force Rhinitis Practice Parameter explicitly discourages single parenteral corticosteroid administration for routine allergic rhinitis and states that recurrent administration is contraindicated — because safer and more effective options are available.
How long do biologic allergy injections like Dupixent need to be taken?
Biologic allergy injections require indefinite administration because they treat disease without inducing allergen-specific tolerance. Dupixent (dupilumab) is given subcutaneously every 2 weeks; stopping it leads to return of atopic dermatitis, asthma, or other Th2-driven symptoms within weeks to months. The same applies to Xolair and Tezspire. This distinguishes biologics fundamentally from allergen immunotherapy (SCIT/SLIT), which has a defined 3-5 year course after which treatment can stop with benefits persisting for years. Biologic costs for indefinite use (typically $15,000-40,000 per year at list price) represent a substantial long-term financial commitment versus the defined endpoint of immunotherapy.
Is epinephrine an allergy injection medication?
Epinephrine auto-injectors (EpiPen, Auvi-Q) and the needle-free neffy nasal spray (FDA-approved August 9, 2024) are emergency rescue medications for anaphylaxis — not allergy treatments in the therapeutic sense. Epinephrine reverses the acute life-threatening cardiovascular and respiratory manifestations of anaphylaxis within minutes. It provides no chronic allergy benefit and is not used preventively. Patients receiving SCIT, Xolair, or other allergy injections may be prescribed an epinephrine auto-injector to use in case of a severe allergic reaction. If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness after any allergy injection, call 911 and use epinephrine immediately.
Related Articles
Allergy Injections Guide: Schedule & Safety | Curex
Allergy injections (SCIT) mean 60-80+ visits over 3-5 years. Cochrane 51 RCTs: SMD -0.73. Learn what goes in the vial, the schedule, and real-world adherence data.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read morePollen Allergy Shot: 3-Way Triage Guide | Curex
Pollen allergy shot triage: depot steroid (discouraged), SLIT tablet, or SCIT. Curex at-home SCIT is category 3: shots weekly at home, $129/month.
Read moreAllergy Injection Site: Anatomy & Technique | Curex
SCIT injections go subcutaneously into the posterolateral upper outer arm, alternating arms each visit. 26-27G needle. Not intramuscular. Not intradermal.
Read morePollen Allergy Shots: Efficacy & Evidence | Curex Guide
Pollen SCIT has the strongest immunotherapy RCT base: grass 49% symptom reduction (Walker 2001), ragweed NEJM 1996, birch 40% (Bødtger 2002). Full regional map inside.
Read moreAllergy Medicine Shot: SCIT vs Xolair vs Steroids | Curex
Allergy medicine shots include SCIT (allergen extract, not a drug), Xolair, Dupixent, and depot steroids. Only SCIT modifies disease. AAAAI discourages routine steroid shots.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.